Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Daré Bioscience, Inc. Prices Underwritten Public Offering of Common Stock
SAN DIEGO , April 09, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), today announced the pricing of an underwritten public offering of 4,575,000 shares of its common stock at a price of $1.10 per share. The company has also granted to the underwriters a 30-day option to acquire an
View HTML
Toggle Summary Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock
SAN DIEGO , April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it intends to offer shares of its common stock in an underwritten public offering.  Daré expects to grant to the underwriters of the offering a 30-day
View HTML
Toggle Summary Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
SAN DIEGO , April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a novel 17β-estradiol and progesterone intravaginal ring in sheep” was published online in the
View HTML
Toggle Summary Daré Bioscience, Inc. Regains Listing Compliance on Nasdaq
SAN DIEGO , April 01, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it received notice from The Nasdaq Stock Market LLC indicating that the Company regained compliance with the minimum bid price requirement in Nasdaq
View HTML
Toggle Summary Daré Bioscience, Inc. to Host Business Update and Full Year 2018 Financial Results Conference Call and Webcast
SAN DIEGO , April 01, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 8:30 a.m. Eastern Time on Thursday, April 4, 2019, to provide an update on portfolio strategic corporate
View HTML
Toggle Summary World-renowned Scientist, Described as the Edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Daré Bioscience Scientific Advisory Board
SAN DIEGO , March 29, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, announced that Dr. Robert Langer , co-inventor of Daré‘s novel, segmented intravaginal ring (IVR) drug delivery technology and one of the 10 Institute Professors at the
View HTML
Toggle Summary Daré Bioscience, Inc. to Present at the 31st Annual ROTH Conference
SAN DIEGO , March 18, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson , President and Chief Executive Officer, will present at the 31st Annual ROTH Conference on Tuesdsay , March 19 th , 2019 starting at 9:30
View HTML
Toggle Summary Daré Bioscience Announces Publication of Positive Clinical Findings for Vaginal Administration of Tamoxifen for the Treatment of VVA
DARE-VVA1 is a proprietary formulation of tamoxifen for vaginal administration as a potential treatment for VVA in patients with hormone-receptor-positive breast cancer SAN DIEGO , March 18, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today
View HTML
Toggle Summary Daré Bioscience receives notification of second award from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the development of Ovaprene®
SAN DIEGO , March 11, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.  (NASDAQ:DARE), a leader in women’s health innovation, today announced that it received a second Notice of Award of $982,851 , part of a grant providing up to $1.9 million in the aggregate for Ovaprene® research from the Eunice
View HTML
Toggle Summary Daré Bioscience, Inc. to Present at the Cowen 39th Annual Healthcare Conference
SAN DIEGO , March 05, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson , President and Chief Executive Officer, will present at the Cowen 39th Annual Healthcare Conference on Tuesday, March 12, 2019 at 8:40
View HTML